Lack of clinically relevant correlation between subjective and objective cognitive function in ICU survivors: a prospective 12-month follow-up study.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
12 07 2019
Historique:
received: 13 03 2019
accepted: 24 06 2019
entrez: 14 7 2019
pubmed: 14 7 2019
medline: 30 1 2020
Statut: epublish

Résumé

Cognitive impairment and psychological distress are common in intensive care unit (ICU) survivors. Early identification of affected individuals is important, so intervention and treatment can be utilized at an early stage. Cognitive Failures Questionnaire (CFQ) is commonly used to screen for subjective cognitive function, but it is unclear whether CFQ scores correlate to objective cognitive function in this population. Between 2014 and 2018, 100 ICU survivors aged 18-70 years from the general ICU at the Karolinska University Hospital, Solna, were included in the study. Out of these, 58 patients completed follow-up at 3 months after ICU discharge, 51 at 6 months, and 45 at 12 months. Follow-up included objective cognitive function testing using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and subjective cognitive function testing with the self-rating Cognitive Failures Questionnaire (CFQ), as well as psychological self-rating with the Post-Traumatic Stress Symptoms Scale-10 (PTSS-10) and Hospital Anxiety and Depression Scale (HADS). The prevalence of cognitive impairment as measured by four selected CANTAB tests was 34% at 3 months after discharge, 18% at 6 months, and 16% at 12 months. There was a lack of significant correlation between CANTAB scores and CFQ scores at 3 months (r = - 0.134-0.207, p > 0.05), at 6 months (r = - 0.106-0.257, p > 0.05), and at 12 months after discharge (r = - 0.070-0.109, p > 0.05). Correlations between CFQ and PTSS-10 scores and HADS scores, respectively, were significant over the follow-up period (r = 0.372-0.710, p ≤ 0.001-0.023). In contrast, CANTAB test scores showed a weak correlation with PTSS-10 and HADS scores, respectively, at 3 months only (r = - 0.319-0.348, p = 0.008-0.015). We found no clinically relevant correlation between subjective and objective cognitive function in this cohort of ICU survivors, while subjective cognitive function correlated significantly with psychological symptoms throughout the follow-up period. Treatment and evaluation of ICU survivors' recovery need to consider both subjective and objective aspects of cognitive impairment, and subjective reports must be interpreted with caution as an indicator of objective cognitive function.

Sections du résumé

BACKGROUND
Cognitive impairment and psychological distress are common in intensive care unit (ICU) survivors. Early identification of affected individuals is important, so intervention and treatment can be utilized at an early stage. Cognitive Failures Questionnaire (CFQ) is commonly used to screen for subjective cognitive function, but it is unclear whether CFQ scores correlate to objective cognitive function in this population.
METHODS
Between 2014 and 2018, 100 ICU survivors aged 18-70 years from the general ICU at the Karolinska University Hospital, Solna, were included in the study. Out of these, 58 patients completed follow-up at 3 months after ICU discharge, 51 at 6 months, and 45 at 12 months. Follow-up included objective cognitive function testing using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and subjective cognitive function testing with the self-rating Cognitive Failures Questionnaire (CFQ), as well as psychological self-rating with the Post-Traumatic Stress Symptoms Scale-10 (PTSS-10) and Hospital Anxiety and Depression Scale (HADS).
RESULTS
The prevalence of cognitive impairment as measured by four selected CANTAB tests was 34% at 3 months after discharge, 18% at 6 months, and 16% at 12 months. There was a lack of significant correlation between CANTAB scores and CFQ scores at 3 months (r = - 0.134-0.207, p > 0.05), at 6 months (r = - 0.106-0.257, p > 0.05), and at 12 months after discharge (r = - 0.070-0.109, p > 0.05). Correlations between CFQ and PTSS-10 scores and HADS scores, respectively, were significant over the follow-up period (r = 0.372-0.710, p ≤ 0.001-0.023). In contrast, CANTAB test scores showed a weak correlation with PTSS-10 and HADS scores, respectively, at 3 months only (r = - 0.319-0.348, p = 0.008-0.015).
CONCLUSION
We found no clinically relevant correlation between subjective and objective cognitive function in this cohort of ICU survivors, while subjective cognitive function correlated significantly with psychological symptoms throughout the follow-up period. Treatment and evaluation of ICU survivors' recovery need to consider both subjective and objective aspects of cognitive impairment, and subjective reports must be interpreted with caution as an indicator of objective cognitive function.

Identifiants

pubmed: 31300016
doi: 10.1186/s13054-019-2527-1
pii: 10.1186/s13054-019-2527-1
pmc: PMC6625117
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

253

Références

Intensive Care Med. 1999 Jul;25(7):697-704
pubmed: 10470573
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
J Consult Psychol. 1956 Oct;20(5):343-50
pubmed: 13367264
J Intensive Care Med. 2004 Sep-Oct;19(5):285-90
pubmed: 15358947
Intensive Care Med. 2004 Nov;30(11):2009-16
pubmed: 15372146
Int Psychogeriatr. 2004 Sep;16(3):275-93
pubmed: 15559753
Anaesthesia. 2005 Apr;60(4):332-9
pubmed: 15766335
Acta Anaesthesiol Scand. 2008 Feb;52(2):202-8
pubmed: 18005373
Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):421-34
pubmed: 18774425
Intensive Care Med. 2009 May;35(5):796-809
pubmed: 19165464
J Psychosom Res. 2010 Jul;69(1):33-41
pubmed: 20630261
PM R. 2010 May;2(5):332-7
pubmed: 20656614
Lancet. 2010 Oct 16;376(9749):1339-46
pubmed: 20934212
Crit Care Med. 2012 Jan;40(1):112-8
pubmed: 21926597
Crit Care Med. 2012 Feb;40(2):502-9
pubmed: 21946660
Psychol Bull. 2012 Mar;138(2):296-321
pubmed: 22181852
Intensive Care Med. 2012 Oct;38(10):1647-53
pubmed: 22777516
Intensive Care Med. 2013 Mar;39(3):376-86
pubmed: 23328935
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
JAMA. 2014 Apr 2;311(13):1308-16
pubmed: 24638143
J Neurol. 2014 Jul;261(7):1300-8
pubmed: 24740819
Lancet Respir Med. 2014 May;2(5):369-79
pubmed: 24815803
Hypertension. 2014 Sep;64(3):653-7
pubmed: 24914204
Resuscitation. 2015 Apr;89:13-8
pubmed: 25596374
Intensive Care Med. 2015 Apr;41(4):708-11
pubmed: 25619483
Ergonomics. 2015;58(9):1471-86
pubmed: 25855858
J Crit Care. 2015 Aug;30(4):793-8
pubmed: 25981443
Health Qual Life Outcomes. 2016 Oct 18;14(1):148
pubmed: 27756403
Crit Care Med. 2018 Jan;46(1):79-84
pubmed: 29068855
J Intensive Care. 2018 Jan 8;6:2
pubmed: 29340154
Crit Care Med. 2018 May;46(5):e479-e480
pubmed: 29652722
Health Qual Life Outcomes. 2018 May 2;16(1):82
pubmed: 29720196
Intensive Care Med. 2019 Jun;45(6):806-814
pubmed: 30840124
Br Med Bull. 1971 Sep;27(3):272-7
pubmed: 4937273
Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):199-209
pubmed: 6125971
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Br J Clin Psychol. 1982 Feb;21 (Pt 1):1-16
pubmed: 7126941
Am J Public Health. 1997 Sep;87(9):1449-55
pubmed: 9314795
Acta Psychiatr Scand. 1997 Oct;96(4):281-6
pubmed: 9350957
Support Care Cancer. 1998 Mar;6(2):101-8
pubmed: 9540167

Auteurs

Emily Brück (E)

Function Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. emily.bruck@sll.se.
Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden. emily.bruck@sll.se.
Department of Physiology and Pharmacology, Karolinska Institutet, 171 77, Stockholm, Sweden. emily.bruck@sll.se.

Jacob W Larsson (JW)

Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Julie Lasselin (J)

Stress Research Institute, Stockholm University, 106 91, Stockholm, Sweden.
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.

Matteo Bottai (M)

The Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, 17177, Stockholm, Sweden.

Tatja Hirvikoski (T)

Department of Women's and Children's Health, KIND, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.

Eva Sundman (E)

Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, 171 77, Stockholm, Sweden.
REMEO Stockholm, Torsten Levenstams väg 4, 128 64, Sköndal, Sweden.

Michael Eberhardson (M)

Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Peter Sackey (P)

Department of Physiology and Pharmacology, Karolinska Institutet, 171 77, Stockholm, Sweden.

Peder S Olofsson (PS)

Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Center for Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, New York, 11030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH